Tumor-targeting drug shows potential for treating bone cancer patients

(University of Texas M. D. Anderson Cancer Center) The treatment of osteosarcoma, the most common tumor of bone, is challenging. A study led by The University of Texas MD Anderson Cancer Center found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news